Author

Niklas Beyhoff

British Heart FoundationORCID 0000-0001-9140-2336Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Philipp MertinsiD· 2 shared Alexander J. SparrowiD· 1 shared Alexandra Maria Chitroceanu· 1 shared Annika WinkleriD· 1 shared Betty RamaniD· 1 shared Burkert Mathias PieskeiD· 1 shared Ceren KoçanaiD· 1 shared Charlotte L. Hooper· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Philipp MertinsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologyCirculationPeer-reviewedAug 18, 2026

Myeloid cell recruitment propels right ventricular dysfunction in HFpEF via sterile inflammation.

Lara Jaeschke, Ceren Koçana, Alexandra Maria Chitroceanu…·Jana Grune

This paper shows that myeloid cell recruitment drives right ventricular dysfunction in HFpEF through sterile inflammation in both mice and humans.

DOI 10.1161/circulationaha.125.078476

𝕏 PostBluesky

Cell BiologybioRxivPreprintJul 24, 2026

Unmasking Supervillin: SVIL haploinsufficiency causes hypertrophic cardiomyopathy by impairing mechanotransduction and cellular energetics.

Yifan Joshua Li, Yiangos Psaras, Violetta Steeples…·Christopher N. Toepfer

This study identifies SVIL haploinsufficiency as a cause of hypertrophic cardiomyopathy by impairing mechanotransduction and cellular energetics, with potential therapeutic implications for mitochondrial-targeted treatments.

DOI 10.64898/2026.07.01.735949

humanbulk RNA-seq

𝕏 PostBluesky